GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Nanjing Vishee Medical Technology Co Ltd (SHSE:688580) » Definitions » Debt-to-Equity

Nanjing Vishee Medical Technology Co (SHSE:688580) Debt-to-Equity : 0.00 (As of Mar. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Nanjing Vishee Medical Technology Co Debt-to-Equity?

Nanjing Vishee Medical Technology Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ¥0.0 Mil. Nanjing Vishee Medical Technology Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ¥0.0 Mil. Nanjing Vishee Medical Technology Co's Total Stockholders Equity for the quarter that ended in Mar. 2024 was ¥1,648.9 Mil. Nanjing Vishee Medical Technology Co's debt to equity for the quarter that ended in Mar. 2024 was 0.00.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Nanjing Vishee Medical Technology Co's Debt-to-Equity or its related term are showing as below:

During the past 10 years, the highest Debt-to-Equity Ratio of Nanjing Vishee Medical Technology Co was 0.14. The lowest was 0.00. And the median was 0.00.

SHSE:688580's Debt-to-Equity is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 0.215
* Ranked among companies with meaningful Debt-to-Equity only.

Nanjing Vishee Medical Technology Co Debt-to-Equity Historical Data

The historical data trend for Nanjing Vishee Medical Technology Co's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nanjing Vishee Medical Technology Co Debt-to-Equity Chart

Nanjing Vishee Medical Technology Co Annual Data
Trend Dec13 Dec14 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.06 - - - -

Nanjing Vishee Medical Technology Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Debt-to-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Nanjing Vishee Medical Technology Co's Debt-to-Equity

For the Medical Devices subindustry, Nanjing Vishee Medical Technology Co's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nanjing Vishee Medical Technology Co's Debt-to-Equity Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Nanjing Vishee Medical Technology Co's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Nanjing Vishee Medical Technology Co's Debt-to-Equity falls into.



Nanjing Vishee Medical Technology Co Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Nanjing Vishee Medical Technology Co's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Nanjing Vishee Medical Technology Co's Debt to Equity Ratio for the quarter that ended in Mar. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Nanjing Vishee Medical Technology Co  (SHSE:688580) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.


Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.


Nanjing Vishee Medical Technology Co Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Nanjing Vishee Medical Technology Co's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Nanjing Vishee Medical Technology Co (SHSE:688580) Business Description

Traded in Other Exchanges
N/A
Address
No. 19 Ningshuang Road, Building 9, Yuhuatai District, Nanjing, CHN, 210012
Nanjing Vishee Medical Technology Co Ltd is engaged in production and sales of rehabilitation medical devices. The company's products under Pelvic floor and postpartum rehabilitation include Pelvic floor electromyography biofeedback instrument; Myotrac series biological stimulation feedback instrument; Ruiyi Series Biostimulation Feedback Apparatus; Magneuro Series Magnetic Stimulator; Female psychological rehabilitation; Neonatal electroencephalograph; Consumables; and under Mental rehabilitation include Multi-parameter biofeedback instrument; Group biofeedback; Magneuro Series Magnetic Stimulator; and Cognitive dysfunction treatment software.
Executives
Huang He Senior management, core technical personnel
Chou Kai Senior management, core technical personnel
Zhong Yi Qun senior management
Chen Li Li Directors, senior managers
Zhang Hui senior management
Gao Fei Core technical personnel
Lian Qing Ming Director

Nanjing Vishee Medical Technology Co (SHSE:688580) Headlines

No Headlines